Lifestyle and Pharmacological Interventions in Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy Interventions: Drug: Sacubitril/Valsartan; Behavioral: Lifestyle Sponsors: Newcastle-upon-Tyne Hospitals NHS Trust; University Hospital Regensburg; Assistance Publique - Hôpitaux de Paris; Azienda Ospedaliero-Universitaria Careggi; Institute for Cardiovascular Diseases of Vojvodina Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Cardiomyopathy | Cardiovascular | Diovan | Heart | Hypertrophic Cardiomyopathy | Research